Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 12, 2010The Journal of Infectious DiseasesOpen Access

Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SYSteven A. YuklSan Francisco VA Medical CenterSGSara GianellaUniversity of California SystemESElizabeth SinclairWellcome Sanger Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yukl et al. (2010) studied this question.

synapsesocial.com/papers/6a8a3c8b9be9d02581bd99e5https://doi.org/10.1086/656722
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intracellular and cell‐free (infectious) HIV‐1 in rectal mucosa2001 · 31 citations
  2. 2The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value1992 · 168 citations
  3. 3Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up1996 · 141 citations
  4. 4Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy2008 · 50 citations
  5. 5The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART2007 · 71 citations